Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| RGBAD (Regen BioPharma Inc.) | NA | 21,481.20% | 1,562.01% | 196.07% | NA | NA | NA | … | … |
Data as of 05/30/2023, Common starting date is 04/20/2016
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| RGBAD (Regen BioPharma Inc.) | 04/20/2016 | 05/30/2023 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | 36.12 | 21,481.20 | 1,562.01 | 196.07 | NA | NA | NA | … | … | 25,150.00 | -60.00 | 1,328.57 | 16.67 | -28.57 | -91.60 | -23.08 | -27.78 |
| Sharpe Ratio | NA | 28.29 | 3.23 | 0.45 | NA | NA | NA | … | … | 73,106.95 | -0.47 | 4.85 | 0.05 | -0.12 | -0.26 | -0.12 | -0.15 |
| Standard Deviation(%) | NA | 756.04 | 483.03 | 431.97 | NA | NA | NA | … | … | 1,177.71 | 129.88 | 273.74 | 327.17 | 254.00 | 350.61 | 195.03 | 252.36 |
| Draw Down(%) | NA | 89.31 | 98.12 | 98.12 | NA | NA | NA | … | … | 80.08 | 64.31 | 88.49 | 86.84 | 89.33 | 92.76 | 73.47 | 83.97 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 05/30/2023, Common starting date is 04/20/2016
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| RGBAD (Regen BioPharma Inc.) |
-73.81%
Nov 2017 – Nov 2020 |
-33.09%
Feb 2018 – Feb 2023 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| RGBAD (Regen BioPharma Inc.) |
1,027.50%
Apr 2020 – Apr 2023 |
176.06%
Mar 2018 – Mar 2023 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart
